A couple..one a pink and another a bulletin board
NEPH- long at 1.26
BIEL- long at .0771
NEPH is a medical device company that got one approval so far for a Dual Stage Ultrafilter that is used to filter biological contaminants from water and bicarbonate concentrate in hemodialysis procedures.
They are waiting on word from the FDA on a few other approvals.
I originally bought this on May 26th ..got in at .32..Sold some at .76, .88, .90 and then the rest at 1.35. It got up to 1.75 at that time..
It sold off a bit and then I got back in at 1.26 ...fucker ripped to 2.63..This time around I sold some at 1.93and some at 2.60..the rest I'm most likely going to ride until the FDA makes their decision on the other potential approvals.
BIEL..I bought this one on pending approvals also...I bought in at .0771 on 8/4..after a few analysts placed a .30 to .50 price target on the stock. They've had some good press releases..most recently the 19th BioElectronics Significantly Strengthens Balance Sheet, Comments on FDA Applications - Yahoo! Finance
If this dips below .07 I'm gonna get more.
Another one I'm intrigued by and played is GETA..another bulleting board stock that has some significant anti-cancer drugs waiting on approval. It used to be listed as GNTA but the company did a reverse stock split and the ticker changed. This one is risky...the FDA has asked for more clinical trials from the company for their newest product. I'm on the sidelines on this one..Might get back in mid september.
My account sucked for a while on some bad plays but NEPH has been very kind to me.
As you see I like to play the small pharma stocks that have FDA approvals looming.


Reply With Quote
